View by Year:
Select Year View All 2019 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000
Jiang L, Tolani B, Yeh CC, Fan Y, Reza JA, Horvai AE, Xia E, Kratz JR, Jablons DM, Mann MJ
Differential gene expression identifies KRT7 and MUC1 as potential metastasis-specific targets in sarcoma.
Cancer management and research , 2019;[epublish]11:8209-8218.
Hung MS, Chen IC, You L, Jablons DM, Li YC, Mao JH, Xu Z, Lung JH, Yang CT, Liu ST
Knockdown of cullin 4A inhibits growth and increases chemosensitivity in lung cancer cells.
Journal of cellular and molecular medicine , Mar-10-2016;[Epub ahead of print].
Lui NS, Yang YW, van Zante A, Buchanan P, Jablons DM, Lemjabbar-Alaoui H
SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer.
PloS one , 2016;[epublish]11(2):e0148911.
Hung MS, Chen IC, You L, Jablons DM, Li YC, Mao JH, Xu Z, Hsieh MJ, Lin YC, Yang CT, Liu ST, Tsai YH
Knockdown of Cul4A increases chemosensitivity to gemcitabine through upregulation of TGFBI in lung cancer cells.
Oncology reports , Dec-2015;34(6):3187-95.
Yang YL, Ni J, Hsu PC, Mao JH, Hsieh D, Xu A, Chan G, Au A, Xu Z, Jablons DM, You L
Cul4A overexpression associated with Gli1 expression in malignant pleural mesothelioma.
Journal of cellular and molecular medicine , Oct-2015;19(10):2385-96. Epub 2015 Jul 27.
Childs EJ, Mocci E, Campa D, Bracci PM, Gallinger S, Goggins M, Li D, Neale RE, Olson SH, Scelo G, Amundadottir LT, Bamlet WR, Bijlsma MF, Blackford A, Borges M, Brennan P, Brenner H, Bueno-de-Mesquita HB, Canzian F, Capurso G, Cavestro GM, Chaffee KG, Chanock SJ, Cleary SP, Cotterchio M, Foretova L, Fuchs C, Funel N, Gazouli M, Hassan M, Herman JM, Holcatova I, Holly EA, Hoover RN, Hung RJ, Janout V, Key TJ, Kupcinskas J, Kurtz RC, Landi S, Lu L, Malecka-Panas E, Mambrini A, Mohelnikova-Duchonova B, Neoptolemos JP, Oberg AL, Orlow I, Pasquali C, Pezzilli R, Rizzato C, Saldia A, Scarpa A, Stolzenberg-Solomon RZ, Strobel O, Tavano F, Vashist YK, Vodicka P, Wolpin BM, Yu H, Petersen GM, Risch HA, Klein AP
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
Nature genetics , Aug-2015;47(8):911-6. Epub 2015 Jun 22.
Wang Y, Xu Z, Mao JH, Hung MS, Hsieh D, Au A, Jablons DM, You L
Analysis of lung tumor initiation and progression in transgenic mice for Cre-inducible overexpression of Cul4A gene.
Thoracic cancer , Jul-2015;6(4):480-7.
Yeh CC, Fan Y, Jiang L, Yang YL, He B, You L, Mann M
Genistein Suppresses Growth of Human Uterine Sarcoma Cell Lines via Multiple Mechanisms.
Anticancer research , Jun-2015;35(6):3167-73.
Wang Y, Xu Z, Mao JH, Hsieh D, Au A, Jablons DM, Li H, You L
PR-Set7 is Degraded in a Conditional Cul4A Transgenic Mouse Model of Lung Cancer.
Zhongguo fei ai za zhi = Chinese journal of lung cancer , Jun-2015;18(6):345-50.
Mo ML, Ma J, Chen Z, Wei B, Li H, Zhou Y, Shi H, Tolani B, Jin JQ, Tseng HH, Shen D, Zhan Y, Li J, Jablons DM, Zhang RQ, Guo Y, He B, Zhou HM
Measurement of genome-wide DNA methylation predicts survival benefits from chemotherapy in non-small cell lung cancer.
Journal of cancer research and clinical oncology , May-2015;141(5):901-8. Epub 2014 Nov 4.
Blakely CM, Pazarentzos E, Olivas V, Asthana S, Yan JJ, Tan I, Hrustanovic G, Chan E, Lin L, Neel DS, Newton W, Bobb KL, Fouts TR, Meshulam J, Gubens MA, Jablons DM, Johnson JR, Bandyopadhyay S, Krogan NJ, Bivona TG
NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.
Cell reports , Apr-7-2015;11(1):98-110. Epub 2015 Apr 2.
You B, Yang YL, Xu Z, Dai Y, Liu S, Mao JH, Tetsu O, Li H, Jablons DM, You L
Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
Oncotarget , Feb-28-2015;6(6):4357-68.
Letteboer TG, Benzinou M, Merrick CB, Quigley DA, Zhau K, Kim IJ, To MD, Jablons DM, van Amstel JK, Westermann CJ, Giraud S, Dupuis-Girod S, Lesca G, Berg JH, Balmain A, Akhurst RJ
Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14.
Frontiers in genetics , 2015;[epublish]6:67.
Woodard GA, Jablons DM
The Latest in Surgical Management of Stage IIIA Non-Small Cell Lung Cancer: Video-Assisted Thoracic Surgery and Tumor Molecular Profiling.
American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting , 2015;e435-41.
Yue D, Li H, Che J, Zhang Y, Tolani B, Mo M, Zhang H, Zheng Q, Yang Y, Cheng R, Jin JQ, Luh TW, Yang C, Tseng HH, Giroux-Leprieur E, Woodard GA, Hao X, Wang C, Jablons DM, He B
EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.
PloS one , 2015;[epublish]10(7):e0132134.
Capelletti M, Dodge ME, Ercan D, Hammerman PS, Park SI, Kim J, Sasaki H, Jablons DM, Lipson D, Young L, Stephens PJ, Miller VA, Lindeman NI, Munir KJ, Richards WG, Jänne PA
Identification of recurrent FGFR3-TACC3 fusion oncogenes from lung adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research , Dec-15-2014;20(24):6551-8. Epub 2014 Oct 7.
Woodard GA, Gubens MA, Jahan TM, Jones KD, Kukreja J, Theodore PR, Cardozo S, Jew G, Clary-Macy C, Jablons DM, Mann MJ
Prognostic molecular assay might improve identification of patients at risk for recurrence in early-stage non-small-cell lung cancer.
Clinical lung cancer , Nov-2014;15(6):426-32. Epub 2014 Aug 15.
Giroux Leprieur E, Hirata T, Mo M, Chen Z, Okamoto J, Clement G, Li H, Wislez M, Jablons DM, He B
The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma.
Lung cancer (Amsterdam, Netherlands) , Sep-2014;85(3):465-71. Epub 2014 Jun 30.
Yang YL, Jablons D, You L
An alternative way to initiate Notch1 signaling in non-small cell lung cancer.
Translational lung cancer research , Aug-2014;3(4):238-41.
Minagawa S, Lou J, Seed RI, Cormier A, Wu S, Cheng Y, Murray L, Tsui P, Connor J, Herbst R, Govaerts C, Barker T, Cambier S, Yanagisawa H, Goodsell A, Hashimoto M, Brand OJ, Cheng R, Ma R, McKnelly KJ, Wen W, Hill A, Jablons D, Wolters P, Kitamura H, Araya J, Barczak AJ, Erle DJ, Reichardt LF, Marks JD, Baron JL, Nishimura SL
Selective targeting of TGF-β activation to treat fibroinflammatory airway disease.
Science translational medicine , Jun-18-2014;6(241):241ra79.
Yang YL, Hung MS, Wang Y, Ni J, Mao JH, Hsieh D, Au A, Kumar A, Quigley D, Fang LT, Yeh CC, Xu Z, Jablons DM, You L
Lung tumourigenesis in a conditional Cul4A transgenic mouse model.
The Journal of pathology , Jun-2014;233(2):113-23.
Bosco-Clément G, Zhang F, Chen Z, Zhou HM, Li H, Mikami I, Hirata T, Yagui-Beltran A, Lui N, Do HT, Cheng T, Tseng HH, Choi H, Fang LT, Kim IJ, Yue D, Wang C, Zheng Q, Fujii N, Mann M, Jablons DM, He B
Targeting Gli transcription activation by small molecule suppresses tumor growth.
Oncogene , Apr-17-2014;33(16):2087-97. Epub 2013 May 20.
Okada N, Lin CP, Ribeiro MC, Biton A, Lai G, He X, Bu P, Vogel H, Jablons DM, Keller AC, Wilkinson JE, He B, Speed TP, He L
A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression.
Genes & development , Mar-1-2014;28(5):438-50. Epub 2014 Feb 14.
Wang Y, Wen M, Kwon Y, Xu Y, Liu Y, Zhang P, He X, Wang Q, Huang Y, Jen KY, LaBarge MA, You L, Kogan SC, Gray JW, Mao JH, Wei G
CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression.
Cancer research , Jan-15-2014;74(2):520-31. Epub 2014 Jan 9.
Fang LT, Lee S, Choi H, Kim HK, Jew G, Kang HC, Chen L, Jablons D, Kim IJ
Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis.
International journal of oncology , Jan-2014;44(1):211-21. Epub 2013 Oct 25.
Yue D, Li H, Che J, Zhang Y, Tseng HH, Jin JQ, Luh TM, Giroux-Leprieur E, Mo M, Zheng Q, Shi H, Zhang H, Hao X, Wang C, Jablons DM, He B
Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas.
Journal of experimental & clinical cancer research : CR , 2014;[epublish]33:34.
Zhang S, Yang YL, Wang Y, You B, Dai Y, Chan G, Hsieh D, Kim IJ, Fang LT, Au A, Stoppler HJ, Xu Z, Jablons DM, You L
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells.
Journal of experimental & clinical cancer research : CR , 2014;[epublish]33:93.
Hung MS, Xu Z, Chen Y, Smith E, Mao JH, Hsieh D, Lin YC, Yang CT, Jablons DM, You L
Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model.
International journal of oncology , Nov-2013;43(5):1517-22. Epub 2013 Sep 04.
Xi Y, Wei Y, Sennino B, Ulsamer A, Kwan I, Brumwell AN, Tan K, Aghi MK, McDonald DM, Jablons DM, Chapman HA
Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia.
Oncogene , Oct-17-2013;32(42):5048-57. Epub 2012 Dec 17.
Ganesan AP, Johansson M, Ruffell B, Yagui-Beltrán A, Beltran A, Lau J, Jablons DM, Coussens LM
Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.
Journal of immunology (Baltimore, Md. : 1950) , Aug-15-2013;191(4):2009-17. Epub 2013 Jul 12.
Zhang S, Long H, Yang YL, Wang Y, Hsieh D, Li W, Au A, Stoppler HJ, Xu Z, Jablons DM, You L
Inhibition of CK2α down-regulates Notch1 signalling in lung cancer cells.
Journal of cellular and molecular medicine , Jul-2013;17(7):854-62. Epub 2013 May 8.
Kratz JR, Tham PT, Mulvihill MS, Ziaei F, Ray MR, Hurst JW, Segal MR, Berryman DM, Chu W, He B, Jablons DM, Mann MJ
Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancer.
Diagnostic molecular pathology : the American journal of surgical pathology, part B , Jun-2013;22(2):65-9.
Mulvihill MS, Kratz JR, Pham P, Jablons DM, He B
The role of stem cells in airway repair: implications for the origins of lung cancer.
Chinese journal of cancer , Feb-2013;32(2):71-4. Epub 2012 Nov 1.
Zhang Y, He J, Zhang F, Li H, Yue D, Wang C, Jablons DM, He B, Lui N
SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma.
Journal of experimental & clinical cancer research : CR , 2013;[epublish]32:7.
Li H, Lui N, Cheng T, Tseng HH, Yue D, Giroux-Leprieur E, Do HT, Sheng Q, Jin JQ, Luh TW, Jablons DM, He B
Gli as a novel therapeutic target in malignant pleural mesothelioma.
PloS one , 2013;8(3):e57346.
Kim IJ, Quigley D, To MD, Pham P, Lin K, Jo B, Jen KY, Raz D, Kim J, Mao JH, Jablons D, Balmain A
Rewiring of human lung cell lineage and mitotic networks in lung adenocarcinomas.
Nature communications , 2013;4:1701.
Mo ML, Chen Z, Zhou HM, Li H, Hirata T, Jablons DM, He B
Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer.
Journal of experimental & clinical cancer research : CR , 2013;[epublish]32:29.
Tsao MS, Jablons DM
Molecular prognostication of non-small cell lung cancer.
Seminars in thoracic and cardiovascular surgery , 2013;25(1):4-7.
Bravo DT, Yang YL, Kuchenbecker K, Hung MS, Xu Z, Jablons DM, You L
Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer.
BMC cancer , 2013;[epublish]13:316.
Liu S, Hsieh D, Yang YL, Xu Z, Peto C, Jablons DM, You L
Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2.
BMC pharmacology & toxicology , 2013;[epublish]14:36.
Mo ML, Okamoto J, Chen Z, Hirata T, Mikami I, Bosco-Clément G, Li H, Zhou HM, Jablons DM, He B
Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.
PloS one , 2013;[epublish]8(8):e71816.
Kratz JR, Van den Eeden SK, He J, Jablons DM, Mann MJ
A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors.
JAMA , Oct-24-2012;308(16):1629-31.
Kim JW, Lee S, Lui N, Choi H, Mulvihill M, Fang LT, Kang HC, Kwon YW, Jablons D, Kim IJ
A somatic TSHR mutation in a patient with lung adenocarcinoma with bronchioloalveolar carcinoma, coronary artery disease and severe chronic obstructive pulmonary disease.
Oncology reports , Oct-2012;28(4):1225-30. Epub 2012 Jul 26.
Li T, Hou SC, Mao JH, Wang YC, Lu XD, Tan JL, You B, Liu YP, Ni J, Au A, Jablons DM, Xu Z, You L
The expression of Dishevelled-3 and glutamine metabolism in malignant pleural mesothelioma.
Journal of clinical pathology , Sep-2012;65(9):855-8. Epub 2012 May 8.
Choi H, Kratz J, Pham P, Lee S, Ray R, Kwon YW, Mao JH, Kang HC, Jablons D, Kim IJ
Development of a rapid and practical mutation screening assay for human lung adenocarcinoma.
International journal of oncology , Jun-2012;40(6):1900-6. Epub 2012 Mar 07.
Yom SS, Chen CP, Jahan TM, Jablons DM
One size does not fit all lung cancer patients.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer , May-2012;7(5):945.
Kratz JR, He J, Van Den Eeden SK, Zhu ZH, Gao W, Pham PT, Mulvihill MS, Ziaei F, Zhang H, Su B, Zhi X, Quesenberry CP, Habel LA, Deng Q, Wang Z, Zhou J, Li H, Huang MC, Yeh CC, Segal MR, Ray MR, Jones KD, Raz DJ, Xu Z, Jahan TM, Berryman D, He B, Mann MJ, Jablons DM
A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies.
Lancet (London, England) , Mar-3-2012;379(9818):823-32. Epub 2012 Jan 27.
Zhang S, Wang Y, Mao JH, Hsieh D, Kim IJ, Hu LM, Xu Z, Long H, Jablons DM, You L
Inhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells.
PloS one , 2012;7(6):e38996.
Mulvihill MS, Kwon YW, Lee S, Fang LT, Choi H, Ray R, Kang HC, Mao JH, Jablons D, Kim IJ
Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells.
PloS one , 2012;7(8):e42264.
Lui NS, van Zante A, Rosen SD, Jablons DM, Lemjabbar-Alaoui H
SULF2 expression by immunohistochemistry and overall survival in oesophageal cancer: a cohort study.
BMJ open , 2012;[epublish]2(6):.
Chen CP, Weinberg VK, Jahan TM, Jablons DM, Yom SS
Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer , Nov-2011;6(11):1857-64.
Markovics JA, Araya J, Cambier S, Somanath S, Gline S, Jablons D, Hill A, Wolters PJ, Nishimura SL
Interleukin-1beta induces increased transcriptional activation of the transforming growth factor-beta-activating integrin subunit beta8 through altering chromatin architecture.
The Journal of biological chemistry , Oct-21-2011;286(42):36864-74. Epub 2011 Aug 30.
Schmid S, Bieber M, Zhang F, Zhang M, He B, Jablons D, Teng NN
Wnt and hedgehog gene pathway expression in serous ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society , Aug-2011;21(6):975-80.
Okamoto J, Kratz JR, Hirata T, Mikami I, Raz D, Segal M, Chen Z, Zhou HM, Pham P, Li H, Yagui-Beltran A, Beltran A, Ray MR, Koizumi K, Shimizu K, Jablons D, He B
Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients.
Clinical lung cancer , Jul-2011;12(4):237-44. Epub 2011 Apr 24.
Li T, Li H, Wang Y, Harvard C, Tan JL, Au A, Xu Z, Jablons DM, You L
The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma.
The Journal of pathology , Mar-2011;223(4):519-30. Epub 2011 Jan 5.
Li T, Hung MS, Wang Y, Mao JH, Tan JL, Jahan K, Roos H, Xu Z, Jablons DM, You L
Transgenic mice for cre-inducible overexpression of the Cul4A gene.
Genesis (New York, N.Y. : 2000) , Mar-2011;49(3):134-41. Epub 2011 Mar 5.
Hung MS, Mao JH, Xu Z, Yang CT, Yu JS, Harvard C, Lin YC, Bravo DT, Jablons DM, You L
Cul4A is an oncogene in malignant pleural mesothelioma.
Journal of cellular and molecular medicine , Feb-2011;15(2):350-8.
Lemjabbar-Alaoui H, Sidhu SS, Mengistab A, Gallup M, Basbaum C
TACE/ADAM-17 phosphorylation by PKC-epsilon mediates premalignant changes in tobacco smoke-exposed lung cells.
PloS one , 2011;[epublish]6(3):e17489.
Barbone D, Ryan JA, Kolhatkar N, Chacko AD, Jablons DM, Sugarbaker DJ, Bueno R, Letai AG, Coussens LM, Fennell DA, Broaddus VC
The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance.
Cell death & disease , 2011;[epublish]2:e174.
Lin YC, Lin CK, Tsai YH, Weng HH, Li YC, You L, Chen JK, Jablons DM, Yang CT
Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells.
Oncology reports , Dec-2010;24(6):1605-12.
Mikami I, Zhang F, Hirata T, Okamoto J, Koizumi K, Shimizu K, Jablons D, He B
Inhibition of activated phosphatidylinositol 3-kinase/AKT pathway in malignant pleural mesothelioma leads to G1 cell cycle arrest.
Oncology reports , Dec-2010;24(6):1677-81.
Okamoto J, Hirata T, Chen Z, Zhou HM, Mikami I, Li H, Yagui-Beltran A, Beltran A, Johansson M, Coussens LM, Clement G, Shi Y, Zhang F, Koizumi K, Shimizu K, Jablons D, He B
EMX2 is epigenetically silenced and suppresses growth in human lung cancer.
Oncogene , Nov-4-2010;29(44):5969-75. Epub 2010 Aug 09.
Ray MR, Jablons D, He B
Lung cancer therapeutics that target signaling pathways: an update.
Expert review of respiratory medicine , Oct-2010;4(5):631-45.
Markovics JA, Araya J, Cambier S, Jablons D, Hill A, Wolters PJ, Nishimura SL
Transcription of the transforming growth factor beta activating integrin beta8 subunit is regulated by SP3, AP-1, and the p38 pathway.
The Journal of biological chemistry , Aug-6-2010;285(32):24695-706. Epub 2010 Jun 2.
Kratz JR, Yagui-Beltrán A, Jablons DM
Cancer stem cells in lung tumorigenesis.
The Annals of thoracic surgery , Jun-2010;89(6):S2090-5.
More SS, Li S, Yee SW, Chen L, Xu Z, Jablons DM, Giacomini KM
Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogue.
Molecular cancer therapeutics , Apr-2010;9(4):1058-69. Epub 2010 Apr 6.
Lemjabbar-Alaoui H, van Zante A, Singer MS, Xue Q, Wang YQ, Tsay D, He B, Jablons DM, Rosen SD
Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis.
Oncogene , Feb-4-2010;29(5):635-46. Epub 2009 Oct 26.
Hung MS, Lin YC, Mao JH, Kim IJ, Xu Z, Yang CT, Jablons DM, You L
Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.
PloS one , 2010;[epublish]5(7):e11418.
Mulshine JL, Jablons DM
Volume CT for diagnosis of nodules found in lung-cancer screening.
The New England journal of medicine , Dec-3-2009;361(23):2281-2.
Gao Z, Xu Z, Hung MS, Lin YC, Wang T, Gong M, Zhi X, Jablons DM, You L
Procaine and procainamide inhibit the Wnt canonical pathway by promoter demethylation of WIF-1 in lung cancer cells.
Oncology reports , Dec-2009;22(6):1479-84.
Ray MR, Jablons DM
Hallmarks of Metastasis
Lung Cancer Metastasis , Sep-18-2009;10.1007/978-1-4419-0772-1(Springer, New York):29-46.
Yagui-Beltrán A, Jablons DM
A translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells.
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia , Aug-2009;15(4):213-20.
Kratz JR, Jablons DM
Genomic prognostic models in early-stage lung cancer.
Clinical lung cancer , May-2009;10(3):151-7.
Kashani-Sabet M, Rangel J, Torabian S, Nosrati M, Simko J, Jablons DM, Moore DH, Haqq C, Miller JR, Sagebiel RW
A multi-marker assay to distinguish malignant melanomas from benign nevi.
Proceedings of the National Academy of Sciences of the United States of America , Apr-14-2009;106(15):6268-72. Epub 2009 Mar 30.
Hung MS, Xu Z, Lin YC, Mao JH, Yang CT, Chang PJ, Jablons DM, You L
Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library.
BMC cancer , 2009;[epublish]9:135.
Raz DJ, Gomez SL, Chang ET, Kim JY, Keegan TH, Pham J, Kukreja J, Hiatt RA, Jablons DM
Epidemiology of non-small cell lung cancer in Asian Americans: incidence patterns among six subgroups by nativity.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer , Dec-2008;3(12):1391-7.
Yagui-Beltran, A., He, B., & Jablons, D.M.
Exploiting the Human Immune System for Lung Cancer Therapy
U.S. Oncology , 2008;[In Press].
Wilson SM, Barbone D, Yang TM, Jablons DM, Bueno R, Sugarbaker DJ, Nishimura SL, Gordon GJ, Broaddus VC
mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids.
American journal of respiratory cell and molecular biology , Nov-2008;39(5):576-83. Epub 2008 May 29.
Yagui-Beltrán A, He B, Jablons DM
The role of cancer stem cells in neoplasia of the lung: past, present and future.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico , Nov-2008;10(11):719-25.
To MD, Wong CE, Karnezis AN, Del Rosario R, Di Lauro R, Balmain A
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
Nature genetics , Oct-2008;40(10):1240-4. Epub 2008 Aug 31.
Okamoto J, Mikami I, Tominaga Y, Kuchenbecker KM, Lin YC, Bravo DT, Clement G, Yagui-Beltran A, Ray MR, Koizumi K, He B, Jablons DM
Inhibition of Hsp90 leads to cell cycle arrest and apoptosis in human malignant pleural mesothelioma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer , Oct-2008;3(10):1089-95.
Raz DJ, Ray MR, Kim JY, He B, Taron M, Skrzypski M, Segal M, Gandara DR, Rosell R, Jablons DM
A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research , Sep-1-2008;14(17):5565-70.
Skrzypski M, Jassem E, Taron M, Sanchez JJ, Mendez P, Rzyman W, Gulida G, Raz D, Jablons D, Provencio M, Massuti B, Chaib I, Perez-Roca L, Jassem J, Rosell R
Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung.
Clinical cancer research : an official journal of the American Association for Cancer Research , Aug-1-2008;14(15):4794-9.
Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM
Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.
Head & neck , Jul-2008;30(7):946-63.
You L, Xu Z, Punchihewa C, Jablons DM, Fujii N
Evaluation of a chemical library of small-molecule Dishevelled antagonists that suppress tumor growth by down-regulating T-cell factor-mediated transcription.
Molecular cancer therapeutics , Jun-2008;7(6):1633-8.
Rosell R, de Las Peñas R, Balaña C, Santarpia M, Salazar F, de Aguirre I, Reguart N, Villa S, Wei J, Ramirez JL, Molina MA, Ramon y Cajal S, Jablons D, Taron M
Translational research in glioblastoma multiforme: molecular criteria for patient selection.
Future oncology (London, England) , Apr-2008;4(2):219-28.
Uematsu K, Seki N, Seto T, Isoe C, Tsukamoto H, Mikami I, You L, He B, Xu Z, Jablons DM, Eguchi K
Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth.
Anticancer research , 2007 Nov-Dec;27(6B):4239-42.
Kim J, Raz D, Jablons D
Unmet need in lung cancer: can vaccines bridge the gap?
Clinical lung cancer , Feb-2008;9 Suppl 1:S6-12.
Clément G, Guilleret I, He B, Yagui-Beltrán A, Lin YC, You L, Xu Z, Shi Y, Okamoto J, Benhattar J, Jablons D
Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus.
Cancer science , Jan-2008;99(1):46-53. Epub 2007 Nov 13.
Reich J, Asaph J
Natural history of stage I lung cancer.
Chest , Dec-2007;132(6):2062; author reply 2062-3.
Uematsu K, Seki N, Seto T, Isoe C, Tsukamoto H, Mikami I, You L, He B, Xu Z, Jablons DM, Eguchi K
Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth.
Anticancer research , 2007 Nov-Dec;27(6B):4239-42.
Shi Y, He B, Kuchenbecker KM, You L, Xu Z, Mikami I, Yagui-Beltran A, Clement G, Lin YC, Okamoto J, Bravo DT, Jablons DM
Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells.
International journal of cancer , Sep-15-2007;121(6):1175-81.
Shi Y, He B, You L, Jablons DM
Roles of secreted frizzled-related proteins in cancer.
Acta pharmacologica Sinica , Sep-2007;28(9):1499-504.
Raz DJ, Kim JY, Jablons DM
Diagnosis and treatment of bronchioloalveolar carcinoma.
Current opinion in pulmonary medicine , Jul-2007;13(4):290-6.
Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM
Natural history of stage I non-small cell lung cancer: implications for early detection.
Chest , Jul-2007;132(1):193-9. Epub 2007 May 15.
Raz DJ, Jablons DM
EGFR expression and mutational analysis as a predictive test.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology , May-20-2007;25(15):2144; author reply 2144-5.
Lee AY, Raz DJ, He B, Jablons DM
Update on the molecular biology of malignant mesothelioma.
Cancer , Apr-15-2007;109(8):1454-61.
Raz DJ, Jablons DM
Five-gene signature in non-small-cell lung cancer.
The New England journal of medicine , Apr-12-2007;356(15):1582; author reply 1583.
Lin YC, You L, Xu Z, He B, Yang CT, Chen JK, Mikami I, Clément G, Shi Y, Kuchenbecker K, Okamoto J, Kashani-Sabet M, Jablons DM
Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth.
Human gene therapy , Apr-2007;18(4):379-86.
Clément G, Jablons DM, Benhattar J
Targeting the Wnt signaling pathway to treat Barrett's esophagus.
Expert opinion on therapeutic targets , Mar-2007;11(3):375-89.
Kim J, You L, Xu Z, Kuchenbecker K, Raz D, He B, Jablons D
Wnt inhibitory factor inhibits lung cancer cell growth.
The Journal of thoracic and cardiovascular surgery , Mar-2007;133(3):733-7.
Raz DJ, Glidden DV, Odisho AY, Jablons DM
Clinical characteristics and survival of patients with surgically resected, incidentally detected lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer , Feb-2007;2(2):125-30.
Fujii N, You L, Xu Z, Uematsu K, Shan J, He B, Mikami I, Edmondson LR, Neale G, Zheng J, Guy RK, Jablons DM
An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth.
Cancer research , Jan-15-2007;67(2):573-9.
Mazières J, Tovar D, He B, Nieto-Acosta J, Marty-Detraves C, Clanet C, Pradines A, Jablons D, Favre G
Epigenetic regulation of RhoB loss of expression in lung cancer.
BMC cancer , 2007;[epublish]7:220.
Kim JY, Harvard C, You L, Xu Z, Kuchenbecker K, Baehner R, Jablons D
Stathmin is overexpressed in malignant mesothelioma.
Anticancer research , 2007 Jan-Feb;27(1A):39-44.
Yagui-Beltrán A, He B, Raz D, Kim J, Jablons DM
Novel therapies targeting signaling pathways in lung cancer.
Thoracic surgery clinics , Nov-2006;16(4):379-96, vi.
Raz DJ, Zell JA, Karnezis AN, Odisho A, Ignatius Ou SH, Anton-Culver H, Jablons DM
Misclassification of bronchioloalveolar carcinoma with cytologic diagnosis of lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer , Nov-2006;1(9):943-8.
Raz DJ, Odisho AY, Franc BL, Jablons DM
Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma.
The Journal of thoracic and cardiovascular surgery , Nov-2006;132(5):1189-95.
To MD, Perez-Losada J, Mao JH, Hsu J, Jacks T, Balmain A
A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice.
Nature genetics , Aug-2006;38(8):926-30. Epub 2006 Jul 02.
Zhou BB, Peyton M, He B, Liu C, Girard L, Caudler E, Lo Y, Baribaud F, Mikami I, Reguart N, Yang G, Li Y, Yao W, Vaddi K, Gazdar AF, Friedman SM, Jablons DM, Newton RC, Fridman JS, Minna JD, Scherle PA
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.
Cancer cell , Jul-2006;10(1):39-50.
To MD, Gokgoz N, Doyle TG, Donoviel DB, Knight JA, Hyslop PS, Bernstein A, Andrulis IL
Functional characterization of novel presenilin-2 variants identified in human breast cancers.
Oncogene , Jun-15-2006;25(25):3557-64. Epub 2006 Feb 13.
Raz DJ, He B, Rosell R, Jablons DM
Current concepts in bronchioloalveolar carcinoma biology.
Clinical cancer research : an official journal of the American Association for Cancer Research , Jun-15-2006;12(12):3698-704.
Raz DJ, Jablons DM
Bronchioloalveolar carcinoma is not associated with younger age at diagnosis: an analysis of the SEER database.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer , May-2006;1(4):339-43.
Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu Z, Lin YC, Clément G, Jablons DM
Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.
Biochemical and biophysical research communications , Apr-21-2006;342(4):1228-32. Epub 2006 Feb 24.
Lin YC, You L, Xu Z, He B, Mikami I, Thung E, Chou J, Kuchenbecker K, Kim J, Raz D, Yang CT, Chen JK, Jablons DM
Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.
Biochemical and biophysical research communications , Mar-10-2006;341(2):635-40. Epub 2006 Jan 17.
Raz DJ, He B, Rosell R, Jablons DM
Bronchioloalveolar carcinoma: a review.
Clinical lung cancer , Mar-2006;7(5):313-22.
He B, Jablons DM
Wnt signaling in stem cells and lung cancer.
Ernst Schering Foundation symposium proceedings , 2006;(5)27-58.
You L, Kim J, He B, Xu Z, McCormick F, Jablons DM
Wnt-1 signal as a potential cancer therapeutic target.
Drug news & perspectives , 2006 Jan-Feb;19(1):27-31.
Kim KU, Wilson SM, Abayasiriwardana KS, Collins R, Fjellbirkeland L, Xu Z, Jablons DM, Nishimura SL, Broaddus VC
A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance.
American journal of respiratory cell and molecular biology , Dec-2005;33(6):541-8. Epub 2005 Aug 25.
Reguart N, He B, Taron M, You L, Jablons DM, Rosell R
The role of Wnt signaling in cancer and stem cells.
Future oncology (London, England) , Dec-2005;1(6):787-97.
Mazieres J, You L, He B, Xu Z, Twogood S, Lee AY, Reguart N, Batra S, Mikami I, Jablons DM
Wnt2 as a new therapeutic target in malignant pleural mesothelioma.
International journal of cancer , Nov-1-2005;117(2):326-32.
To MD, Perez-Losada J, Mao JH, Balmain A
Crosstalk between Pten and Ras signaling pathways in tumor development.
Cell cycle (Georgetown, Tex.) , Sep-2005;4(9):1185-8. Epub 2005 Sep 19.
Taron M, Ichinose Y, Rosell R, Mok T, Massuti B, Zamora L, Mate JL, Manegold C, Ono M, Queralt C, Jahan T, Sanchez JJ, Sanchez-Ronco M, Hsue V, Jablons D, Sanchez JM, Moran T
Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research , Aug-15-2005;11(16):5878-85.
Mazieres J, You L, He B, Xu Z, Lee AY, Mikami I, McCormick F, Jablons DM
Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis.
Oncogene , Aug-11-2005;24(34):5396-400.
To MD, Faseruk SA, Gokgoz N, Pinnaduwage D, Done SJ, Andrulis IL
LAF-4 is aberrantly expressed in human breast cancer.
International journal of cancer , Jul-1-2005;115(4):568-74.
He B, Barg RN, You L, Xu Z, Reguart N, Mikami I, Batra S, Rosell R, Jablons DM
Wnt signaling in stem cells and non-small-cell lung cancer.
Clinical lung cancer , Jul-2005;7(1):54-60.
Mazieres J, He B, You L, Xu Z, Jablons DM
Wnt signaling in lung cancer.
Cancer letters , May-10-2005;222(1):1-10.
He B, Reguart N, You L, Mazieres J, Xu Z, Lee AY, Mikami I, McCormick F, Jablons DM
Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations.
Oncogene , Apr-21-2005;24(18):3054-8.
He B, Lee AY, Dadfarmay S, You L, Xu Z, Reguart N, Mazieres J, Mikami I, McCormick F, Jablons DM
Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
Cancer research , Feb-1-2005;65(3):743-8.
Mikami I, You L, He B, Xu Z, Batra S, Lee AY, Mazieres J, Reguart N, Uematsu K, Koizumi K, Jablons DM
Efficacy of Wnt-1 monoclonal antibody in sarcoma cells.
BMC cancer , 2005;[epublish]5:53.
Lee AY, He B, You L, Xu Z, Mazieres J, Reguart N, Mikami I, Batra S, Jablons DM
Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma.
Biochemical and biophysical research communications , Oct-29-2004;323(4):1246-50.
Reguart N, He B, Xu Z, You L, Lee AY, Mazieres J, Mikami I, Batra S, Rosell R, McCormick F, Jablons DM
Cloning and characterization of the promoter of human Wnt inhibitory factor-1.
Biochemical and biophysical research communications , Oct-8-2004;323(1):229-34.
Lee AY, He B, You L, Dadfarmay S, Xu Z, Mazieres J, Mikami I, McCormick F, Jablons DM
Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma.
Oncogene , Aug-26-2004;23(39):6672-6.
You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I, Reguart N, Moody TW, Kitajewski J, McCormick F, Jablons DM
Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells.
Oncogene , Aug-12-2004;23(36):6170-4.
Mao JH, To MD, Perez-Losada J, Wu D, Del Rosario R, Balmain A
Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression.
Genes & development , Aug-1-2004;18(15):1800-5.
You L, He B, Xu Z, Uematsu K, Mazieres J, Fujii N, Mikami I, Reguart N, McIntosh JK, Kashani-Sabet M, McCormick F, Jablons DM
An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth.
Cancer research , Aug-1-2004;64(15):5385-9.
Beseth BD, Cameron RB, Leland P, You L, Varricchio F, Kreitman RJ, Maki RA, Jablons DM, Husain SR, Puri RK
Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts.
The Annals of thoracic surgery , Aug-2004;78(2):436-43; discussion 436-43.
Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, Reguart N, Rosell R, McCormick F, Jablons DM
Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.
Cancer research , Jul-15-2004;64(14):4717-20.
You L, He B, Uematsu K, Xu Z, Mazieres J, Lee A, McCormick F, Jablons DM
Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells.
Cancer research , May-15-2004;64(10):3474-8.
He B, You L, Xu Z, Mazieres J, Lee AY, Jablons DM
Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
Clinical lung cancer , May-2004;5(6):366-70.
Nemunaitis J, Sterman D, Jablons D, Smith JW, Fox B, Maples P, Hamilton S, Borellini F, Lin A, Morali S, Hege K
Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.
Journal of the National Cancer Institute , Feb-18-2004;96(4):326-31.
He B, You L, Uematsu K, Xu Z, Lee AY, Matsangou M, McCormick F, Jablons DM
A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells.
Neoplasia (New York, N.Y.) , 2004 Jan-Feb;6(1):7-14.
You L, He B, Xu Z, McCormick F, Jablons DM
Future directions: oncolytic viruses.
Clinical lung cancer , Jan-2004;5(4):226-30.
He B, You L, Uematsu K, Zang K, Xu Z, Lee AY, Costello JF, McCormick F, Jablons DM
SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.
Proceedings of the National Academy of Sciences of the United States of America , Nov-25-2003;100(24):14133-8.
Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM
Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression.
Oncogene , Oct-16-2003;22(46):7218-21.
Horvai AE, Li L, Xu Z, Kramer MJ, Jablons DM, Treseler PA
c-Kit is not expressed in malignant mesothelioma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc , Aug-2003;16(8):818-22.
Jablons DM, Cheng SJ, Carolyn Clary-Macy RN, Hirsch FR
1st International Lung Cancer Conference in Beijing, October 27-30, 2002.
Lung cancer (Amsterdam, Netherlands) , Aug-2003;41(2):237-44.
Fjellbirkeland L, Cambier S, Broaddus VC, Hill A, Brunetta P, Dolganov G, Jablons D, Nishimura SL
Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissue.
The American journal of pathology , Aug-2003;163(2):533-42.
Uematsu K, Kanazawa S, You L, He B, Xu Z, Li K, Peterlin BM, McCormick F, Jablons DM
Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin.
Cancer research , Aug-1-2003;63(15):4547-51.
Jensen RH, Tiirikainen M, You L, Ginzinger D, He B, Uematsu K, Xu Z, Treseler P, McCormick F, Jablons DM
Genomic alterations in human mesothelioma including high resolution mapping of common regions of DNA loss in chromosome arm 6q.
Anticancer research , 2003 May-Jun;23(3B):2281-9.
Horvai AE, Li L, Xu Z, Kramer MJ, Jablons DM, Treseler PA
Malignant mesothelioma does not demonstrate overexpression or gene amplification despite cytoplasmic immunohistochemical staining for c-Erb-B2.
Archives of pathology & laboratory medicine , Apr-2003;127(4):465-9.
He B, You L, Uematsu K, Matsangou M, Xu Z, He M, McCormick F, Jablons DM
Cloning and characterization of a functional promoter of the human SOCS-3 gene.
Biochemical and biophysical research communications , Feb-7-2003;301(2):386-91.
Yang CT, You L, Lin YC, Lin CL, Mccormick F, Jablons DM
A comparison analysis of anti-tumor efficacy of adenoviral gene replacement therapy (p14ARF and p16INK4A) in human mesothelioma cells.
Anticancer research , 2003 Jan-Feb;23(1A):33-8.
Lim M, Jablons DM
Matrix metalloproteinase expression in lung cancer.
Methods in molecular medicine , 2003;74:349-56.
Massion PP, Kuo WL, Stokoe D, Olshen AB, Treseler PA, Chin K, Chen C, Polikoff D, Jain AN, Pinkel D, Albertson DG, Jablons DM, Gray JW
Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway.
Cancer research , Jul-1-2002;62(13):3636-40.
Xia C, Xu Z, Yuan X, Uematsu K, You L, Li K, Li L, McCormick F, Jablons DM
Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides.
Molecular cancer therapeutics , Jul-2002;1(9):687-94.
Xu, Z., Eng, K., Badduke, C., Xia, C., Uematsu, K., Yagui-Beltran, A., & Jablons DM.
Molecular Classification of Non-small Cell Lung Cancer by Oligonucleotide Microarray Hybridization Using Sense RNA (sRNA) Generated Via in vitro Transcription
Clinical Cancer Research. , 2002;7(11):3685S-3685S.
Uematsu K, Yoshimura A, Gemma A, Mochimaru H, Hosoya Y, Kunugi S, Matsuda K, Seike M, Kurimoto F, Takenaka K, Koizumi K, Fukuda Y, Tanaka S, Chin K, Jablons DM, Kudoh S
Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis.
Cancer research , Dec-1-2001;61(23):8527-33.
Yang CT, You L, Uematsu K, Yeh CC, McCormick F, Jablons DM
p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53.
Cancer research , Aug-15-2001;61(16):5959-63.
Strickler HD, Strickler HD
A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology , May-2001;10(5):523-32.
Xu Z, Jablons DM, Gruenert DC
Expression sequence tag-specific full-length cDNA cloning: actin cDNAs.
Gene , Jan-24-2001;263(1-2):265-72.
Yang CT, You L, Yeh CC, Chang JW, Zhang F, McCormick F, Jablons DM
Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells.
Journal of the National Cancer Institute , Apr-19-2000;92(8):636-41.
You L, Yang CT, Jablons DM
ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.
Cancer research , Feb-15-2000;60(4):1009-13.